HVEM Signalling Promotes Colitis
Open Access
- 18 April 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (4) , e18495
Abstract
Tumor necrosis factor super family (TNFSF) members regulate important processes involved in cell proliferation, survival and differentiation and are therefore crucial for the balance between homeostasis and inflammatory responses. Several members of the TNFSF are closely associated with inflammatory bowel disease (IBD). Thus, they represent interesting new targets for therapeutic treatment of IBD. We have used mice deficient in TNFSF member HVEM in experimental models of IBD to investigate its role in the disease process. Two models of IBD were employed: i) chemical-induced colitis primarily mediated by innate immune cells; and ii) colitis initiated by CD4+CD45RBhigh T cells following their transfer into immuno-deficient RAG1-/- hosts. In both models of disease the absence of HVEM resulted in a significant reduction in colitis and inflammatory cytokine production. These data show that HVEM stimulatory signals promote experimental colitis driven by innate or adaptive immune cells.Keywords
This publication has 33 references indexed in Scilit:
- T Cell Intrinsic Heterodimeric Complexes between HVEM and BTLA Determine Receptivity to the Surrounding MicroenvironmentThe Journal of Immunology, 2009
- T cell transfer model of chronic colitis: concepts, considerations, and tricks of the tradeAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- A Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral LoadsJournal of Virology, 2008
- A crucial role for HVEM and BTLA in preventing intestinal inflammationJournal of Experimental Medicine, 2008
- Targeting lymphocyte activation through the lymphotoxin and LIGHT pathwaysImmunological Reviews, 2008
- CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediatorNature Immunology, 2008
- TREM-1–expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseasesJournal of Clinical Investigation, 2007
- NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumorsBlood, 2006
- Targeted Disruption of LIGHT Causes Defects in Costimulatory T Cell Activation and Reveals Cooperation with Lymphotoxin β in Mesenteric Lymph Node GenesisJournal of Experimental Medicine, 2002
- The three HveA receptor ligands, gD, LT-α and LIGHT bind to distinct sites on HveAMolecular Immunology, 2000